Menu

AVITA Medical, Inc. RCEL

Full chart Compare
Set alert

Price alert · RCEL

All alert types
15.68 USD -0.64 (-3.92%)

At closeNov 5, 2026, 7:27 PM EST

16.69 +1.01 +6.44%

After hours · Nov 5, 7:27 PM ET

15.02 Day range 16.31
3.22 52-week range 16.90
YTD
+354.49%
1 year
+348.00%

Revenue & Expenses

Revenue by
United States → Revenue: $68.79MRevenue → Gross Profit: $58.82MGross Profit → Expenses: $58.82MRevenue → Cost of Revenue: $12.79MExpenses → Selling, General & Admin: $80.51MExpenses → Research & Development: $20.84MExpenses → Interest Expense: $5.00MExpenses → Other Expenses: $1.04MExpenses → Income Tax: $11.00KNet Loss → Expenses: $48.59MJapan → Revenue: $2.09MAustralia → Revenue: $200.00KEuropean Union → Revenue: $49.00KGross Profit$58.82MNet Loss$48.59MCost of Revenue$12.79MExpenses$107.40MSelling, General & Admin$80.51MResearch & Development$20.84MInterest Expense$5.00MOther Expenses$1.04MIncome Tax$11.00KRevenue$71.61MUnited States$68.79MJapan$2.09MAustralia$200.00KEuropean Union$49.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

RCEL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
71.61M64.25M51.57M37.64M34.62M
58.82M55.16M43.79M31.59M28.51M
-42.53M-56.59M-42.66M-27.50M-25.12M
-48.59M-61.84M-35.38M-26.66M-25.14M
-1.74-2.39-1.40-1.07-1.01
RCEL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
10.24M14.05M22.12M18.16M55.71M
56.39M79.71M111.64M98.26M116.02M
73.04M74.97M61.89M12.97M11.39M
45.12M45.09M41.51M306.00K918.00K
-16.65M4.50M49.06M84.74M104.62M
RCEL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-31.20M-48.94M-38.01M-19.09M-5.50M
12.45M37.36M1.61M-19.33M-49.68M
14.94M3.51M40.37M900.00K7.00K
-1.64M-9.17M-1.38M-452.00K-65.00K
-3.81M-8.07M3.95M-37.55M-55.23M